Harvard, MA, United States of America

Simon Steward Jones


Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Simon Steward Jones

Introduction

Simon Steward Jones, an inventive force based in Harvard, MA, is recognized for his significant contributions to the field of pharmaceuticals. With two patented innovations to his name, Simon is making strides in the treatment of B-cell disorders, particularly cancer.

Latest Patents

Simon Steward Jones holds two remarkable patents, showcasing his innovative approach to cancer treatment. The first patent focuses on "Methods of use and pharmaceutical combinations of histone deacetylase inhibitors and CD20 inhibitory antibodies." This patent details pharmaceutical combinations that comprise an HDAC6 selective inhibitor and a CD20 inhibitory antibody for treating B-cell disorders, such as cancer. The method involves administering an effective amount of these components to patients in need.

His second patent, "Biomarkers to identify patients that will respond to treatment," outlines methods for utilizing biomarkers to identify cancer patients likely to respond to treatment. This invention explores the use of gene expression levels, gene mutations, and studies of various cancer types to predict patient responsiveness to histone deacetylase inhibitors. It also discusses the optional treatment of such patients with an HDAC inhibitor, either alone or in combination with other therapies.

Career Highlights

Simon is associated with Acetylon Pharmaceuticals, Inc., where he utilizes his expertise to advance cancer treatment solutions. His research and innovative solutions aim to enhance patient outcomes and pave the way for novel therapeutic strategies.

Collaborations

Throughout his career, Simon has collaborated with notable colleagues, including Chengyin Min and Steven N Quayle. These partnerships highlight the collaborative spirit in driving forward the frontiers of medical science and innovation.

Conclusion

Simon Steward Jones exemplifies the spirit of innovation in pharmaceutical research. With his groundbreaking patents and a commitment to improving treatment for B-cell disorders, Simon continues to pave the way for advancements that can significantly impact patient care in the realm of cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…